RPL37A-DT

Across TCGA pan-cancer cohorts, RPL37A-DT RNA is linked to patient survival in 26 of 34 cancer types, making it the most broadly survival-associated RPL37A-DT data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher RPL37A-DT RNA is associated with better overall survival. In most high-consensus cancer types, elevated RPL37A-DT expression acts as an unfavorable survival marker, although some lineages such as UCS and ESCA show a favorable association.

UCS, COAD, and ACC are the cancer types where RPL37A-DT RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	OS	Quartile	II,III,IV	0.887	0.333	.001	92	view →
COAD	OS	Median	II,III,IV	0.491	0.695	.001	70	view →
ACC	DFS	Median	All	0.255	0.608	.001	69	view →
KIRC	DFS	Median	III,IV	0.669	0.812	.002	35	view →
LIHC	DFS	Quartile	All	0.467	0.649	.002	32	view →
HNSC	DFS	Quartile	All	0.293	0.450	.001	23	view →
ESCA	DFS	Tertile	II,III,IV	1.000	0.212	.005	18	view →
LAML	DFS	Tertile	All	0.614	0.294	.010	16	view →
UCEC	OS	Quartile	All	0.887	0.957	.002	16	view →
OV	OS	Tertile	III,IV	0.727	0.645	.021	14	view →
BLCA	OS	Tertile	IV	0.669	0.483	.026	9	view →
CESC	DFS	Tertile	All	0.763	0.859	.009	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 26 lineages.

RPL37A-DT–UCS (OS)

Open the UCS breakdown →